| Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102) |
|---|
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | US7179596 Solid support comprising biopolymers for detection of biological/chemical warfare agents |
| 02/15/2007 | WO2007017591A2 Guar extract-containing composition and se of a guar extract in the form of a surface treating and/or modifying agent |
| 02/15/2007 | WO2007017590A2 Guar protein extract product and method for the production and use thereof |
| 02/14/2007 | EP1044983B1 Antibiotic tkr2999, process for the preparation thereof and microbe |
| 02/14/2007 | CN1300328C Protein hydrol ysater enriched in peptides having a carboxy termina proline residue |
| 02/13/2007 | US7176276 Antimicrobial peptide and use thereof |
| 02/13/2007 | US7176275 Peptides of the Bacillus anthracis Anthrax Toxin Lethal factor Protein pX01-107, antibodies specific for the peptides and methods of stimulating immune response; antisense agents |
| 02/08/2007 | US20070032636 Chimeric retroviral Gag genes and screening assays |
| 02/08/2007 | US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 02/07/2007 | CN1909979A Method for coating an object with hydrophobin at low temperature |
| 02/07/2007 | CN1908007A Extraction method of plant total protein and special extract for the same |
| 01/30/2007 | US7169919 Genetically engineered lipids for use in the treatment baterial infection |
| 01/25/2007 | WO2007010623A1 Novel polypeptide and method for producing the same |
| 01/25/2007 | WO2006031607A3 A method of treating cancer |
| 01/18/2007 | WO2006105448A3 Proliferation of muc1 expressing cells |
| 01/16/2007 | US7163918 Attachment to carrier peptide; increasing absorption of through intestinal epithelia; bioavailability, reliability, sustained release |
| 01/16/2007 | US7163695 Histidine copolymer and methods for using same |
| 01/10/2007 | CN1894272A 蛋白质表达 Protein expression |
| 01/04/2007 | US20070004904 G-csf conjugates |
| 01/04/2007 | CA2613193A1 Thrombospondin-1 derived peptides and treatment methods |
| 01/02/2007 | US7157422 Glycogen synthase kinase-3 inhibitors |
| 12/28/2006 | WO2006138721A1 Anti-gfralpha3 antibodies |
| 12/28/2006 | WO2004041067A3 Prevention and treatment of synucleinopathic disease |
| 12/28/2006 | CA2612417A1 Anti-gfralpha3 antibodies |
| 12/21/2006 | WO2005062967A3 Novel anti-il 13 antibodies and uses thereof |
| 12/20/2006 | EP1732596A2 Therapeutic use of rm1 antigen |
| 12/13/2006 | EP1730278A1 Method for preparation and purification of recombinant proteins |
| 12/13/2006 | EP1730192A2 Compositions and methods for detecting cyclic analogs of human parathyroid hormone (hpth) |
| 12/12/2006 | US7148022 Assay for anti-viral agent |
| 12/07/2006 | US20060276622 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 12/07/2006 | US20060276621 Glycosylated specificity exchangers |
| 12/05/2006 | US7144985 Diagnosis of diabetes using antibody |
| 11/30/2006 | WO2006128027A1 Functionally active recombinant peptides, methods for producing same and interactions with other peptides |
| 11/30/2006 | US20060270829 G-csf conjugates |
| 11/29/2006 | EP1299724B1 Synthetic peptide for neurological disorders |
| 11/23/2006 | WO2006123926A2 Peptide composition for growing and/or culturing micro-organisms and/or cells |
| 11/23/2006 | WO2005086967A3 Therapeutic use of rm1 antigen |
| 11/23/2006 | US20060264605 Polypeptides having anti-HIV activity and compositions comprising same |
| 11/23/2006 | US20060264604 Anti-HBs monoclonal antibody |
| 11/21/2006 | US7138486 Insulinotropic hormone derivatives and uses thereof |
| 11/16/2006 | US20060258841 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 11/14/2006 | US7135549 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 11/02/2006 | WO2006116737A2 Compounds and methods for modulating cadherin-mediated processes |
| 11/02/2006 | EP1006785B1 Antimicrobial proteins |
| 11/02/2006 | CA2606227A1 Compounds and methods for modulating cadherin-mediated processes |
| 10/31/2006 | US7129337 Hepatitis C virus (HCV) polynucleic acid of given nucleotide sequence unique to at least one of the new HCV subtypes 7,9,10 OR 11, OR TO SUBTYPES 1D, 1E, 1F, 1G, 2E, 2F, 2G, 2H, 2I, 2K, 2L,3G,4K OR 4M; producing recombinant polypeptide |
| 10/26/2006 | WO2006112738A1 Novel peptides and methods for the treatment of inflammatory disorders |
| 10/26/2006 | US20060241016 For isolating low molecular weight peptides from animal tissue; prevention of initial dissolution of higher molecular weight fraction proteins by in situ denaturation within the tissue, by an organic solvent (preferably ethanol), prior to aqueous extraction |
| 10/19/2006 | US20060235199 Reagent for amplifying amyloid fibrosis of amyloid ss-protein |
| 10/17/2006 | US7122330 Intron containing eukaryotic gene; posttranslation; glycosylation; protein folding |
| 10/12/2006 | US20060229432 synthetic vaccine; HIV; multi-antigenic construct comprising carbohydrate antigens linked with polypeptides |
| 10/11/2006 | EP0751782B1 Use of a non-neutralizing antibody specific for the beta-subunit of luteinizing hormone for enhancing fertility |
| 10/10/2006 | US7119171 A fibronectin type III (Fn3) monobody polypeptide consisting of two to six beta -strand domains with a loop region linked between each beta-strand domain, and such polypeptide is capable of binding to a target molecule |
| 10/05/2006 | CA2610292A1 Proliferation of muc1 expressing cells |
| 10/03/2006 | US7115708 For therapy of cancer; for therapy of disorders associated with voltage-gated ion channels, ligand gated channels and other receptors |
| 09/28/2006 | US20060216302 Immunological markers |
| 09/27/2006 | EP1703994A2 Method for coating an object with hydrophobin in the presence of a detergent |
| 09/26/2006 | US7112654 Ligand for vascular endothelial growth factor receptor |
| 09/21/2006 | WO2006098074A1 Apoptosis inducing agent for prostate carcinoma cell |
| 09/21/2006 | WO2002050303A3 Protein-protein interactions |
| 09/20/2006 | EP0929569B1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/19/2006 | US7108856 Comprise viral amino acid sequences for use in vaccine preparation and prevention of viral infection |
| 09/14/2006 | WO2003089588A3 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 09/14/2006 | US20060205923 For detecting the presence of FIV antibodies in a biological sample, bycontacting a biological sample from an animal with the FIV polypeptide |
| 09/14/2006 | US20060204966 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor |
| 09/05/2006 | US7101851 IgE receptor antagonists |
| 08/31/2006 | US20060193847 Peptides for inhibiting retroviruses |
| 08/29/2006 | US7097837 Synthetic vaccine agents |
| 08/23/2006 | CN1823086A Oligopeptide |
| 08/22/2006 | US7094406 Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof |
| 08/17/2006 | WO2003087124A3 Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/09/2006 | EP1073891B1 Method of predicting receptor modulating activity |
| 08/09/2006 | CN1816348A Improved heat shock protein-based vaccines and immunotherapies |
| 08/03/2006 | WO2004007746A3 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN |
| 07/27/2006 | WO2003085086A3 Motif-grafted hybrid polypeptides and uses thereof |
| 07/20/2006 | WO2003084467A3 Epitope constructs comprising antigen presenting cell targeting mechanisms |
| 07/11/2006 | US7074761 Drug for hormone-sensitive tumors; glandular disorders; antiulcer agents; sleep disorders; gene therapy; Alzheimer's disease; genetic engineered polypeptide |
| 07/06/2006 | US20060149032 Recombinant hepatitis B surface antigen |
| 07/04/2006 | US7070807 Administering polypeptide by injection; gene therapy |
| 07/04/2006 | US7070790 peptides and recombinant envelope 1 and core proteins derived from specific gene sequences and their use in diagnostic methods and vaccines. |
| 06/29/2006 | WO2006066358A1 Vacuole targeting peptide and nucleic acid |
| 06/28/2006 | CN1793169A Sea snail toxin variant polypeptide compound, its preparation process and application thereof |
| 06/27/2006 | US7067624 Antimicrobial proteins |
| 06/22/2006 | US20060135746 Peptide used to inhibit the binding of HIV to cell surface receptor CD4 |
| 06/21/2006 | EP1670899A2 Vaccines for cancer, autoimmune disease and infections |
| 06/21/2006 | CN1791427A Method and composition of a novel vaccine design for the prevention and treatment of SARS |
| 06/15/2006 | US20060128941 Pokeweed antiviral protein polypeptides with antiviral activity |
| 06/14/2006 | CN1787831A Methods for preventing mitochondrial permeability transition |
| 06/13/2006 | US7060283 capable of binding with antibody in a specimen from an individual with Epstein-Barr virus (EBV)-associated disease; diagnosis and treatment of EBV-associated disease |
| 06/08/2006 | WO2006004620A3 Enterotoxin gene cluster (egc) superantigens to treat malignant disease |
| 06/08/2006 | WO2005120563A3 Induction of an immune response against streptococcus pneumoniae polysaccharides |
| 06/08/2006 | WO2005117957A3 Compositions and methods involving o-acetylated group b streptococcus capsular polysaccharides |
| 06/08/2006 | US20060122368 Antigen delivery platform |
| 06/08/2006 | US20060122107 Method of modulating cellular activity and molecules for use therein |
| 06/06/2006 | US7056511 contacting said cells with a free light chain of immunoglobulin-binding peptide having a specific amino sequence; may be used to treat asthma, allergy, including contact allergy and occupational allergy, chronic inflammatory bowel disorders, viral infection, multiple sclerosis. and migraines |
| 05/31/2006 | EP1661908A1 Reagent for amplifying amyloid fibrosis of amyloid beta-protein |
| 05/31/2006 | EP1604032A4 Method for detecting prognosis of cancer |